Keith Goss, DPM
Foot & Ankle Surgery · Chandler, AZNPI 1700860715
Payments from drug & device makers
What this record shows
This record is dominated by other: $133,445 of the $134,934 with a category attached, or 98.9%. Medshape, Inc. accounts for 98.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $133,675 and has fallen 99.8% since, to $286 in 2025. Among foot & ankle surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $3748.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medshape, Inc.$133K
- Smith+Nephew$770
- Organogenesis Inc.$295
- Surgenex LLC$173
- Stryker$113
- Arbor Pharmaceuticals, Inc.$45
- plus $93 from 5 others
What the payments were for
- Food & beverage$1,4891%
- Other$133,44599%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medshape, Inc. | 1 | $133,445 |
| Smith+Nephew | 21 | $770 |
| Organogenesis Inc. | 3 | $295 |
| Surgenex LLC | 1 | $173 |
| Stryker | 1 | $113 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Tactile Systems Technology Inc | 2 | $34 |
| Amgen | 1 | $17 |
| Medtronic | 1 | $16 |
| Antares Pharma, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$224
- SurGraft$173
- SurMatrix$173
- ArdeoGraft$173
- PelloGraft$173
- RenoGraft$173
- PROSTEP MICA$113
How this compares
$134,934 in reported general payments places this provider in the 95th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 94 | $811 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $446 |
| Doxycycline Hyclate | 95 | $326 |
| Terbinafine Hcl | 19 | $111 |
| Cephalexin | 15 | $80 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Chandler
- Myron HansenChandler$480K
- Urja ShahChandler$20K
- Vanousheh GhandhariChandler$11K
- Raul AvilesChandler$11K
- Ryan ScottPhoenix$1.1M
- Jeffrey McAlisterScottsdale$578K
- Jeffrey HolmesPhoenix$509K
- Scott MalingMesa$382K
- Melissa GalliPhoenix$324K
- Geoffrey LandisTucson$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.